Healthcare >> Analyst Interviews >> July 14, 2003
Keay T. Nakae is a Vice President and Research Analyst with Wedbush
Morgan Securities' Life Sciences Research Group, and currently focuses
on medical device companies. His research provides coverage on
innovative life-enhancing technologies. Prior to joining Wedbush Morgan
Securities, he spent five years at ARCO in various corporate finance
roles, including two years managing a portfolio of derivative financial
instruments. Before ARCO, he spent five years at St. Jude Medical as an
Engineer in cardiac pacemaker research and development. Mr. Nakae holds
an MBA in Finance from the Anderson School at the University of
California at Los Angeles and MS and BS degrees in Electronic
Engineering from Cal Poly, San Luis Obispo. Profile
devices area?
Mr. Nakae: Most of my coverage is centered on companies involved in
cardiovascular disease, so that includes
